BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19903744)

  • 1. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.
    Woolcott CG; Shvetsov YB; Stanczyk FZ; Wilkens LR; White KK; Caberto C; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Endocr Relat Cancer; 2010 Mar; 17(1):125-34. PubMed ID: 19903744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study.
    Setiawan VW; Haiman CA; Stanczyk FZ; Le Marchand L; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1849-55. PubMed ID: 17035391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women.
    McTiernan A; Wu L; Barnabei VM; Chen C; Hendrix S; Modugno F; Rohan T; Stanczyk FZ; Wang CY;
    Breast Cancer Res Treat; 2008 Mar; 108(2):217-31. PubMed ID: 18297397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
    Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.
    Kim Y; Franke AA; Shvetsov YB; Wilkens LR; Cooney RV; Lurie G; Maskarinec G; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Goodman MT
    BMC Cancer; 2014 Jan; 14():29. PubMed ID: 24438060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
    Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
    Zhang X; Tworoger SS; Eliassen AH; Hankinson SE
    Breast Cancer Res Treat; 2013 Feb; 137(3):883-92. PubMed ID: 23283524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
    Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
    Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex hormone levels after menopause and subsequent breast cancer.
    Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G
    J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic plasma pyridoxal 5'-phosphate (vitamin b6) levels and invasive breast carcinoma risk: the multiethnic cohort.
    Lurie G; Wilkens LR; Shvetsov YB; Ollberding NJ; Franke AA; Henderson BE; Kolonel LN; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1942-8. PubMed ID: 22879204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
    J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of sex steroid hormones with mortality in women with breast cancer.
    Duggan C; Stanczyk F; Campbell K; Neuhouser ML; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard R; McTiernan A
    Breast Cancer Res Treat; 2016 Feb; 155(3):559-67. PubMed ID: 26865065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of BMI and physical activity to sex hormones in postmenopausal women.
    McTiernan A; Wu L; Chen C; Chlebowski R; Mossavar-Rahmani Y; Modugno F; Perri MG; Stanczyk FZ; Van Horn L; Wang CY;
    Obesity (Silver Spring); 2006 Sep; 14(9):1662-77. PubMed ID: 17030978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.